Layer, Chiang, et al. Genome Biology
SomaLogic Launching Validation and Prospective Trials for Protein Biomarker Lung Cancer Diagnostic
The test is intended both for early screening purposes and the differential diagnoses of lung nodules detected during CT scans and x-rays. SomaLogic has partnered with Quest Diagnostics to commercialize the test, with a lab-developed version slated for launch next year.
New to GenomeWeb? Register here quickly.